Tumor-targeted quantum dots can help surgeons find tumor boundaries

IEEE Transactions on Nanobioscience

Volumn 8, Issue 1, 2009, Pages 65-71

  Arndt Jovin, Donna J ^a   Kantelhardt, Sven R ^b   Caarls, Wouter ^a   De Vries, Anthony H B ^a   Giese, Alf ^b   Jovin, Thomas M ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cellular imaging; Confocal microscopy; Epidermal growth factor (EGF); Epidermal growth factor receptor (EGFR); Experimental intraoperative imaging; Extent of resection; Glioma; Programmable array microscope (PAM) microscopy

Indexed keywords

CELLULAR IMAGING; EPIDERMAL GROWTH FACTOR (EGF); EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); EXPERIMENTAL INTRAOPERATIVE IMAGING; EXTENT OF RESECTION; GLIOMA; PROGRAMMABLE ARRAY MICROSCOPE (PAM) MICROSCOPY;

ANIMAL CELL CULTURE; ASSOCIATIVE STORAGE; BIOACTIVITY; CELL CULTURE; CELL MEMBRANES; CONFOCAL MICROSCOPY; IMAGING TECHNIQUES; LABELS; ONCOLOGY; PEPTIDES; PNEUMATIC DRIVES; PULSE AMPLITUDE MODULATION; SEMICONDUCTOR QUANTUM DOTS;

TUMORS;

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BIOPSY; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN TARGETING; SENSITIVITY AND SPECIFICITY; SURGEON; TUMOR CELL CULTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GLIOMA; HUMANS; IMAGE ENHANCEMENT; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBE TECHNIQUES; QUANTUM DOTS; SENSITIVITY AND SPECIFICITY;

EID: 68149107680     PISSN: 15361241     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNB.2009.2016548     Document Type: Article

References (30)

1. J. Huang, K. Chen, W. Gong, Y. Zhou, Y. Le, X. Bian, and J. M. Wang, "Receptor "hijacking" by malignant glioma cells: A tactic for tumor progression," Cancer Lett., vol. 267, pp. 254-261, Apr. 2008.
2. M. Lacroix, D. Abi-Said, D. R. Fourney, Z. L. Gokaslan, W. Shi, F. De-Monte, F. F. Lang, I. E. McCutcheon, S. J. Hassenbusch, E. Holland, K. Hess, C. Michael, D. Miller, and R. Sawaya, "A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival," J. Neurosurg., vol. 95, pp. 190-198, Aug. 2001.
3. A. Cambi, D. Lidke, D. Arndt-Jovin, C. Figdor, and T. M. Jovin, "Ligandconjugated quantum dots monitor antigen uptake and processing by dendritic cells," Nano Lett., vol. 7, pp. 970-977, 2007.
4. M. M. Echarte, L. Bruno, D. A. Arndt-Jovin, T. M. Jovin, and L. Pietrasanta, "Quantitative single particle tracking of NGF-receptor complexes: Transport is bidirectional but biased by longer retrograde run lengths," FEBS Lett., vol. 581, pp. 2905-2913, May 2007.
5. D. S. Lidke, K. A. Lidke, B. Rieger, T. M. Jovin, and D. J. Arndt-Jovin, "Reaching out for signals: Filopodia sense EGF and respond by directed retrograde transport of activated receptors," J. Cell Biol., vol. 170, pp. 619-626, 2005.
6. J. L. Nakamura, "The epidermal growth factor receptor in malignant gliomas: Pathogenesis and therapeutic implications," Exp. Opin. Ther. Targets, vol. 11, pp. 463-472, Apr. 2007.
7. M. E. Halatsch, U. Schmidt, J. Behnke-Mursch, A. Unterberg, and C. R. Wirtz, "Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours," Cancer Treat. Rev., vol. 32, pp. 74-89, Apr. 2006.
8. M. K. Nicholas, R. V. Lukas, N. F. Jafri, L. Faoro, and R. Salgia, "Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas," Clin. Cancer Res., vol. 12, pp. 7261-7270, Dec. 2006.
9. The Cancer Genome Atlas Research Network, "Comprehensive genomic characterization defines human glioblastoma genes and core pathways," Nature, vol. 455, pp. 1061-1068, Sep. 2008.
10. D. W. Parsons, S. Jones, X. Zhang, J. C.-H. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I. M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, Jr., J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. N. Marie, S. M. O. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, and K. W. Kinzler, "An integrated genomic analysis of human glioblastoma multiforme," Science, vol. 321, pp. 1807-1812, Sep. 2008.
11. C. Franco-Hernandez, V. Martinez-Glez, M. E. Alonso, J. M. De Campos, A. Isla, J. Vaquero, M. Gutierrez, and J. A. Rey, "Gene dosage and muta tional analyses of EGFR in oligodendrogliomas," Int. J. Oncol., vol. 30, pp. 209-215, Jan. 2007.
12. G. Hagen, W. Caarls, M. Thomas, A. Hill, K. Lidke, B. Rieger, C. Fritsch, B. van Geest, T. Jovin, and D. Arndt-Jovin, "Biological applications of an LCoS-based programmable array microscope (PAM)," Proc. SPIE, vol. 6441, pp. 64410S1-64410S12, 2007.
13. D. B. Ramnarain, S. Park, D. Y. Lee, K. J. Hatanpaa, S. O. Scoggin, H. Otu, T. A. Libermann, J. M. Raisanen, R. Ashfaq, E. T. Wong, J. Wu, R. Elliott, and A. A. Habib, "Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells," Cancer Res., vol. 66, pp. 867-874, Jan. 2006.
14. J. D. Sato, T. Kawamoto, A. D. Le, J. Mendelsohn, J. Polikoff, and G. H. Sato, "Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors," Mol. Biol. Med., vol. 1, pp. 511-529, Dec. 1983.
15. S. R. Kantelhardt, D. J. Arndt-Jovin, W. Caarls, A. H. B. de Vries, G. M. Hagen, W. Schulz-Schäfer, V. Rohde, T. M. Jovin, and A. Giese, "Utility of EGFR-targeted quantum dots to distinguish glioma cells in live brain tissue," submitted for publication.
16. A. Giese, R. Bjerkvig, M. E. Berens, and M. Westphal, "Cost of migration: Invasion of malignant gliomas and implications for treatment," J. Clin. Oncol., vol. 21, pp. 1624-1636, Apr. 2003.
17. D. S. Oh and P. M. Black, "A low-field intraoperative MRI system for glioma surgery: Is it worthwhile?," Neurosurg. Clin. N. Amer., vol. 16, pp. 135-141, 2005.
18. W. Stummer, H. J. Reulen, T. Meinel, U. Pichlmeier, W. Schumacher, J. C. Tonn, V. Rohde, F. Oppel, B. Turowski, C. Woiciechowsky, K. Franz, and T. Pietsch, "Extent of resection and survival in glioblastoma multi forme: Identification of and adjustment for bias," Neurosurgery, vol. 62, pp. 564-576, Mar. 2008 (discussion).
19. S. R. Kantelhardt, H. Diddens, J. Leppert, V. Rohde, G. Huttmann, and A. Giese, "Multiphoton excitation fluorescence microscopy of 5-aminolevulinic acid induced fluorescence in experimental gliomas," Lasers Surg. Med., vol. 40, pp. 273-281, Apr. 2008.
20. R. Tréhin, J. L. Figueiredo, M. J. Pittet, R. Weissleder, L. Josephson, and U. Mahmood, "Fluorescent nanoparticle uptake for brain tumor visualization," Neoplasia, vol. 8, pp. 302-311, Apr. 2006.
21. H. Jackson, O. Muhammad, H. Daneshvar, J. Nelms, A. Popescu, M. A. Vogelbaum, M. Bruchez, and S. A. Toms, "Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas," Neurosurgery, vol. 60, pp. 524-529, Mar. 2007 (discussion: pp. 529-530).
22. D. S. Lidke and D. J. Arndt-Jovin, "Imaging takes a quantum leap," Physiology, vol. 19, pp. 322-325, 2004.
23. A. Mauro and A. Bulfone, "Oncogenes and growth factors in gliomas," J. Neurosurg. Sci., vol. 34, pp. 171-173, Jul.-Dec. 1990.
24. P. Tang, P. A. Steck, and W. K. Yung, "The autocrine loop of TGF-alpha/EGFR and brain tumors," J. Neurooncol., vol. 35, pp. 303-314, Dec. 1997.
25. X. Michalet, F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. Sundaresan, A. M. Wu, S. S. Gambhir, and S. Weiss, "Quantum dots for live cells, in vivo imaging, and diagnostics," Science, vol. 307, pp. 538-544, Jan. 2005.
26. A. M. Smith, G. Ruan, M. N. Rhyner, and S. M. Nie, "Engineering luminescent quantum dots for in vivo molecular and cellular imaging," Ann. Biomed. Eng., vol. 34, pp. 3-14, Jan. 2006.
27. X. Zhang, D. Neiner, S. Wang, A. Y. Louie, and S. M. Kauzlarich, "A new solution route to hydrogen-terminated silicon nanoparticles: Synthesis, functionalization and water stability," Nanotechnology, vol. 18, pp. 095601-1-095601-6, 2007.
28. M. Puputti, O. Tynninen, H. Sihto, T. Blom, H. Maenpaa, J. Isola, A. Paetau, H. Joensuu, and N. N. Nupponen, "Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas," Mol. Cancer Res., vol. 4, pp. 927-934, Dec. 2006.
29. H. K. Thorarinsdottir, M. Santi, R.McCarter, E.J.Rushing,R. Cornelison, A. Jales, and T. J. Macdonald, "Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survivalinchildhood gliomas," Clin. Cancer Res., vol. 14, pp. 3386-3394, Jun. 2008.
30. F. Zeppernick, R. Ahmadi, B. Campos, C. Dictus, B. M. Helmke, N. Becker, P. Lichter, A. Unterberg, B. Radlwimmer, and C. C. Herold-Mende, "Stem cell marker CD133 affects clinical outcome in glioma patients," Clin. Cancer Res., vol. 14, pp. 123-129, Jan. 2008.